FDA expanding access to pancreatic cancer drug to some patients
Sentiment Mix
Expert Signals
CBS News - Top Stories
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.
Supported by 1 story
Related Events
Scientists just discovered what coffee is really doing to your gut and brain - ScienceDaily
Uncategorized • 5/4/2026
Fight over online access to abortion pill reaches Supreme Court in emergency appeal - CNN
Uncategorized • 5/3/2026
Abortion pill maker asks to restore mail access
Uncategorized • 5/4/2026
Fashion’s Faustian pact: the high cost of Jeff Bezos’s Met Gala patronage - The Guardian
Uncategorized • 5/3/2026
A new online tool for tackling irritable bowel syndrome - Université de Montréal
Uncategorized • 5/3/2026